Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
A van der LaanJan J Piek

Abstract

During the last decennium, the role of bone marrow mononuclear cells (BMMC) has been underscored in the healing process after acute myocardial infarction (AMI). Although these cells improve left ventricular recovery after AMI in experimental studies, results from large-scale randomised trials investigating BMMC therapy in patients with AMI have shown contradictory results. To address this issue the HEBE study was designed, a multicentre, randomised trial, evaluating the effects of intracoronary infusion of BMMCs and the effects of intracoronary infusion of peripheral blood mononuclear cells after primary percutaneous coronary intervention. The primary endpoint of the HEBE trial is the change in regional myocardial function in dysfunctional segments at four months relative to baseline, based on segmental analysis as measured by magnetic resonance imaging. The results from the HEBE trial will provide detailed information about the effects of intracoronary BMMC therapy on post-infarct left ventricular recovery. In addition, further analysis of the data and material obtained may provide important mechanistic insights into the contribution of BMMCs to natural recovery from AMI as well as the response to cell therapy. This may signif...Continue Reading

References

Apr 5, 2001·Nature·D OrlicP Anversa
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·D OrlicP Anversa
Jan 5, 2002·The New England Journal of Medicine·Federico QuainiPiero Anversa
Jun 12, 2003·Annals of the New York Academy of Sciences·Donald Orlic
Sep 23, 2006·The New England Journal of Medicine·Volker SchächingerUNKNOWN REPAIR-AMI Investigators
Oct 24, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Stefanie DimmelerAndreas M Zeiher
Feb 22, 2008·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Alexander HirschFelix Zijlstra
Mar 28, 2008·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·E J van den BosD J Duncker
Dec 31, 2008·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Rachel T van BeemCarlijn Voermans

❮ Previous
Next ❯

Citations

Jun 19, 2010·Journal of Cardiovascular Translational Research·Ma Eugenia Vázquez-AlvarezFrancisco Fernández-Avilés
Jan 12, 2010·Annual Review of Medicine·Stefan Janssens
Jun 23, 2010·BMC Genomics·Tineke C T M van der Pouw KraanAnton J G Horrevoets
Mar 19, 2011·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Einar HoppHans-Jørgen Smith
Mar 9, 2012·Cardiology Research and Practice·Duc Thang VuTheo Kofidis
Apr 15, 2010·The International Journal of Cardiovascular Imaging·E E van der WallJ J Bax
May 11, 2010·The International Journal of Cardiovascular Imaging·E E van der WallJ H Reiber
Nov 26, 2009·The International Journal of Cardiovascular Imaging·E E van der WallM J Schalij
Aug 25, 2010·The International Journal of Cardiovascular Imaging·E E van der WallJ J Bax
Feb 23, 2010·The International Journal of Cardiovascular Imaging·E E van der Wall
May 27, 2009·The International Journal of Cardiovascular Imaging·E E van der WallM J Schalij
Jun 24, 2010·The International Journal of Cardiovascular Imaging·E E van der WallM J Schalij
Jul 14, 2010·The International Journal of Cardiovascular Imaging·E E van der WallJ D Schuijf
Jun 14, 2014·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·E E van der Wall
Mar 1, 2012·Canadian Journal of Physiology and Pharmacology·Latifa S AbdelliDinender K Singla
May 11, 2010·The International Journal of Cardiovascular Imaging·E E van der WallJ J Bax
Aug 14, 2009·Expert Review of Cardiovascular Therapy·Juan C Chachques
Jun 26, 2010·European Journal of Heart Failure·Ibrahim J DomianPeter van der Meer
Oct 9, 2015·Canadian Journal of Physiology and Pharmacology·Jagjit PaddaSanjiv Dhingra
Jul 6, 2010·Journal of Molecular and Cellular Cardiology·Philippe Menasche
Sep 12, 2012·Stem Cells International·Pablo Díez VillanuevaFrancisco Fernández-Avilés
Nov 16, 2010·Stem Cells International·Ricardo Sanz-RuizFrancisco Fernández-Avilés
Feb 24, 2010·Nature Reviews. Cardiology·Kai C Wollert, Helmut Drexler
Oct 15, 2011·Tissue Engineering. Part B, Reviews·Joyce DoornJan de Boer
Oct 27, 2012·Expert Review of Cardiovascular Therapy·Michelle KrekeEduardo Marbán
Oct 1, 2015·The Cochrane Database of Systematic Reviews·Sheila A FisherEnca Martin-Rendon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.